Los Altos, CA, United States of America

Ernest J Prisbe


 

 

Average Co-Inventor Count = 3.7

ph-index = 12

Forward Citations = 636(Granted Patents)


Location History:

  • Santa Fe Springs, CA (US) (1982)
  • Los Altos, CA (US) (1986 - 2010)

Company Filing History:


Years Active: 1982-2010

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Ernest J. Prisbe**

Introduction

Ernest J. Prisbe, an accomplished inventor based in Los Altos, CA, has made significant contributions to the field of pharmaceutical innovation. With a total of 23 patents to his name, Prisbe is recognized for his groundbreaking work in nucleotide analogs and prodrugs, which hold implications for retroviral and hepadnaviral therapies.

Latest Patents

Among his latest patents, Prisbe has developed novel prodrugs of phosphonate nucleotide analogues. This innovative method identifies mixed ester-amidates of PMPA that are effective for therapeutic applications against retroviral or hepadnaviral infections. The patents also describe compositions of these compounds in pharmaceutically acceptable excipients, enhancing their use in therapy and prophylaxis.

Additionally, his work on nucleotide analogs showcases compounds characterized by amidates linked to amino acids or ester-linked groups, which bond to the phosphorus atom of phosphonate nucleotide analogs. These analogs are designed with a phosphoamidate or ester bond that can be hydrolyzed in vivo, yielding essential phosphonate nucleotide analogs. The patents encompass methods and intermediates for their synthesis and applications, reflecting Prisbe’s innovative prowess in drug development.

Career Highlights

Throughout his illustrious career, Ernest J. Prisbe has been associated with prominent companies such as Gilead Sciences, Inc. and Syntex (U.S.A.) Inc., where he has played a vital role in advancing pharmaceutical research and innovation. His extensive work has significantly influenced the therapeutic landscape, enhancing drug options available for patients.

Collaborations

During his tenure, Prisbe collaborated with esteemed coworkers, including John C. Rohloff and Lawrence R. McGee, who contributed to the success of various projects. These collaborations have fostered an environment of innovation and excellence, resulting in numerous advancements in the pharmaceutical field.

Conclusion

Ernest J. Prisbe stands out as a leading inventor whose contributions to nucleotide analogs and prodrugs have paved the way for novel therapeutic solutions. His extensive patent portfolio reflects his commitment to innovation, with implications for treating viral infections effectively. As pharmaceutical technology continues to evolve, Prisbe’s work will undoubtedly remain influential in the pursuit of advanced therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…